Faster epigenetic aging tracks metabolic syndrome risk in CARDIA
In CARDIA adults with blood methylation clocks, higher MetS severity scores associated with intrinsic epigenetic age acceleration, and year-20 IEAA predicted incident MetS by year 30 (OR 1.05 per unit).
Source
Epigenetic age acceleration and metabolic syndrome in the coronary artery risk development in young adults study
Study at a glance
- Design
- Cohort — CARDIA whole-blood methylation clocks (IEAA/EEAA) related to MetS
- N
- N=957 · Year-20 methylation sample with acceptable quality (year 15 n=1042)
- Population
- CARDIA adults with whole-blood DNA methylation at examinations 15 and/or 20
- Outcome
- Associations of epigenetic age acceleration with MetS severity and incident MetS
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
In the Coronary Artery Risk Development in Young Adults (CARDIA) study, authors profiled whole-blood DNA methylation (Illumina MethylationEPIC) at examination years 15 and 20, computed intrinsic and extrinsic epigenetic age acceleration (IEAA/EEAA), and related these clocks to MetS severity and later incident MetS.
What they found
MetS severity associated positively with IEAA at years 15 and 20 (both P=0.016) and with EEAA at year 20 (P=0.040). Each additional MetS component linked to about +0.29 years of IEAA. Year-20 IEAA associated with incident MetS at year 30 (OR 1.05, 95% CI 1.01–1.10).
The limits
What it doesn't show
Association of methylation age with MetS is not proof that slowing epigenetic clocks prevents MetS. OR 1.05 per IEAA unit is modest and needs context of score scale. Blood clocks are surrogates, not organ-specific MetS mechanisms.
Key terms
- IEAA / EEAA
- Intrinsic vs extrinsic epigenetic age acceleration from DNA methylation clocks.
- MetS severity score
- Composite reflecting how many/how severe metabolic syndrome components are.
- CARDIA
- Coronary Artery Risk Development in Young Adults longitudinal cohort.
- Incident MetS
- New metabolic syndrome by year 30 predicted from year-20 IEAA.
- MethylationEPIC
- Illumina array (~850k sites) used for blood epigenomic profiling.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
Year-20 IEAA predicted?
Common questions
Which cohort?
CARDIA — young adults followed with exams including years 15, 20, and 30.
What clocks were used?
Intrinsic and extrinsic epigenetic age acceleration (IEAA and EEAA) from blood methylation.
Cross-sectional finding?
Higher MetS severity associated with higher IEAA (years 15 and 20) and EEAA (year 20).
Longitudinal finding?
Year-20 IEAA associated with incident MetS at year 30 (OR 1.05, 95% CI 1.01–1.10).
Does this prove anti-aging MetS therapy?
No — it links epigenetic age acceleration with MetS risk; causal prevention is unproven here.
More on Diabetes